Eslicarbazepine as a Treatment for Vestibular Paroxysmia: Preliminary Results
Eslicarbazepine shows good preliminary results achieving symptomatic relief in patients diagnosed with vestibular paroxysmia. Its enhanced safety profile with less adverse effects and drug interactions with respect to standard therapies could facilitate therapeutical adherence without detriment of its efficacy.
Authors
- Vanesa Pérez-Guillén
- Silvina Gómez (ORCID: https://orcid.org/0009-0005-3371-3669)
- Ana Belén Castilla-Jiménez
Institutions
- Hospital Universitari i Politècnic La Fe (ES)
- Foundation for Human Potential (US)
Publication Details
- Journal
- Otology & Neurotology
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1097/mao.0000000000004618
- Primary Topic
- Vestibular and auditory disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00